Moolec Science (MLECW) Inventory Average (2023 - 2026)
Moolec Science (MLECW) posted Inventory Average of $3.8 million for Q1 2026, up 21.88% sequentially from $3.1 million in Q4 2025.
Moolec Science (MLECW) Inventory Average (2023 - 2026) Analysis & Trends
Moolec Science has reported Inventory Average for 4 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Inventory Average changed N/A year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (changed N/A YoY) and the FY2025 annual result came in at $64.1 million, down 46.13% from the prior year.
- Inventory Average improved to $3.8 million in Q1 2026 per MLECW's latest filing, from $3.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $65.8 million in Q3 2024 and troughed at $444234.0 in Q1 2024.
- A 4-year average of $25.8 million and a median of $4.5 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2024 and 2025: Inventory Average soared 1068.59% in 2024, then slumped 94.39% in 2025.
- Over 4 years, Inventory Average stood at $445937.5 in 2023, then jumped by 1068.59% to $5.2 million in 2024, then slumped by 40.17% to $3.1 million in 2025, then advanced by 21.88% to $3.8 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $3.8 million, $3.1 million, and $3.5 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Dec 31, 2024 | 5.21 Mn |
| Sep 30, 2024 | 65.75 Mn |
| Jun 30, 2024 | 63.16 Mn |
| Mar 31, 2024 | 444,234.00 |
| Dec 31, 2023 | 445,937.50 |
| Sep 30, 2023 | 56.20 Mn |
| Jun 30, 2023 | 56.27 Mn |